Impact of secondary prevention on mortality after a first ischemic stroke in Puerto Rico

Puerto Rico Health Sciences Journal

Volumn 36, Issue 1, 2017, Pages 11-16

  Rojas, María E ^a   Marsh, Wallace ^b   Felici Giovanini, Marcos E ^c   Rodríguez Benitez, Rosa J ^d   Zevallos, Juan C ^e  

^a UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c Tobacco Control and Prevention Division   (Puerto Rico)

^d UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Acute ischemic stroke; Cerebrovascular disease; First ischemic stroke; Mortality; Secondary prevention therapy

Indexed keywords

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; PUERTO RICO; REGISTER; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PUERTO RICO; REGISTRIES; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; STROKE; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 85014700695     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007;1:e114.
2. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol 2007;6:182-187.
3. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76:S85-90.
4. Hughes S. Stroke costs to Double by 2030: AHA Statement. Available at: Url: http://www.medscape.com/viewarticle/804583. Accessed May 22, 2013.
5. Centers for Disease Control and Prevention (CDC). Prevalence of stroke--United States, 2005. MMWR Morb Mortal Wkly Rep 2007;56:469-474.
6. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 2011;123:e18-e209.
7. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013;127:143-152.
8. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005;111:1327-1331.
9. CDC State Heart Disease and Stroke Prevention Programs. Paul Coverdell National Acute Stroke Registry. Centers for Disease Control and Prevention website. Available at: Url: http://www.cdc.gov/dhdsp/programs/stroke_registry.htm. March 14, 2012. Accessed March 15, 2012.
10. Fedder W. National and international quality initiatives to improve stroke care. Neurol Clin 2008;26:1191-1207, xi.
11. Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep 2008;56:1-120.
12. National Stroke Association. Stroke 101 Fact Sheet. Updated 2012; Available at: Url: http://www.stroke.org/site/DocServer/STROKE101_2009.pdf?docID=4541. Accessed Feb 12, 2012.
13. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015;131:e29-322.
14. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee. J Hum Hypertens 1998;12:627-629.
15. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-745.
16. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
17. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
18. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Eze-kowitz MD, et al.; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Associa-tion/American Stroke Association. Stroke 2014; 45:2160-2236.
19. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke 2003;34:2475-2481.
20. George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, et al.; Centers for Disease Control and Prevention (CDC). Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ 2009;58:1-23.
21. Monsanto HA, Renta-Muñoz A, Dones W, Comulada A, Cidre C, Orengo JC. The Puerto Rico Cardiovascular Risk-Estimation Study (PRCaRES): an exploratory assessment of new patients in physicians’ offices. P R Health Sci J 2014;33:58-64.
22. Pérez CM, Sánchez H, Ortiz AP. Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico. J Community Health 2013;38:1140-1146.
23. Zevallos J, Santiago F, González J, Rodríguez A, Pericchi L, Rodríguez-Mercado R, Nobo U. Burden of stroke in Puerto Rico. Int J Stroke 2015;10:117-119.
24. Allen NB, Kaltenbach L, Goldstein LB, Olson DM, Smith EE, Peterson ED, et al. Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. Stroke 2012;43:1858-1864.
25. Amar J, Cambou JP, Touzé E, Bongard V, Jullien G, Vahanian A, et al. Comparison of hypertension management after stroke and myocardial infarction: results from ECLAT1--a French nationwide study. Stroke 2004;35:1579-1583.
26. Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke 2002;33: 1656-1659.
27. Touzé E, Cambou JP, Ferrières J, Vahanian A, Coppé G, Leizorovicz A, et al. Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies. Cerebrovasc Dis 2005;20:78-84.
28. Centers for Disease Control and Prevention (CDC). Use of a registry to improve acute stroke care--seven states, 2005-2009. MMWR Morb Mortal Wkly Rep 2011;60:206-210.
29. Shakur R, Sathasivam S, Yu C, Cheung I, Selvakumaran A, Anandarajah C, et al. Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines. JRSM Short Rep 2011;2:63.
30. Asberg S, Henriksson KM, Farahmand B, Asplund K, Norrving B, Appel-ros P, et al. Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register. Stroke 2010;41:1338-1342.
31. Alhusban A, Fagan SC. Secondary prevention of stroke in the elderly: a review of the evidence. Am J Geriatr Pharmacother 2011;9:143-152.
32. Touzé E, Coste J, Voicu M, Kansao J, Masmoudi R, Doumenc B, et al. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study. Stroke 2008;39: 1834-1843.
33. LaBresh KA, Reeves MJ, Frankel MR, Albright D, Schwamm LH. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the “Get With The Guidelines” program. Arch Intern Med 2008;168:411-417.
34. Sierra C, Coca A, Schiffrin EL. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep 2011;13:200-207.
35. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689-701.
36. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67:181-198.
37. Schwamm LH, Fonarow GC, Reeves MJ, Pan W, Frankel MR, Smith EE, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation 2009;119:107-115.